Tag archive for ‘Joseph Papa’

Perrigo buys Crohn’s disease drug for $380 million

  Perrigo will acquire Entocort (budesonide) capsules as well as the authorized generic capsules marketed by Par Pharmaceuticals within the US from AstraZeneca plc for $380 million. Entocort, a gastroenterology More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Jewish Business News On Friday, November 13th, 2015

Mylan’s Hostile Bid For Drug Giant Perrigo Failed

  Mylan N.V. (NASDAQ: MYL; TASE) today announced that its offer to acquire all of the issued and to be issued share capital of Perrigo Company plc (NYSE: PRGO; TASE) has lapsed. Perrigo ordinary shares, More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
News Brief On Friday, November 13th, 2015

Mylan’s hostile bid for Ireland-based drugs giant Perrigo likely to fail

    If confirmed, the outcome would represent a major victory for Perrigo’s defiant Chief Executive Joseph Papa, and a bitter blow to Mylan’s Executive Chairman Robert Coury, who More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
News Brief On Tuesday, November 3rd, 2015

Why Mylan is taking its Perrigo pursuit to Tel Aviv’s stock exchange

Shares in the U.S. generic drugmaker Mylan will begin trading on the Tel Aviv Stock Exchange Wednesday, the TASE said Monday. The move comes after Mylan last week won an Israeli court ruling rejecting Perrigo’s More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Gali Raz On Friday, October 30th, 2015

U.S. Court Denies Perrigo’s Attempt to Block Mylan’s Takeover Bid

Mylan N.V., which made a hostile takeover bid for Perrigo Co., said Friday that a U.S. District court denied Perrigo’s attempt to block the potential closing of Mylan’s proposed offer before shareholders. The More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Ilan Shavit On Tuesday, October 13th, 2015

Mylan to pitch today to Perrigo shareholders in hostile takeover bid

  The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday,  5 pm,  conference call to pitch the buyout to Perrigo shareholders. Perrigo has rejected the $27 billion buyout More...

Niva Goldberg On Friday, September 11th, 2015

Perrigo CEO calls Mylan offer ‘grossly inadequate’; Israeli shareholder rejects the bid

  Trying to fend off a hostile takeover attempt by Mylan’s $27 billion bid, Perrigo Chairman, President and CEO Joseph Papa sent a letter to Mylan Executive Chairman Robert Coury to ‘clarifying More...

Niva Goldberg On Tuesday, June 2nd, 2015

Perrigo To Acquires OTC portfolio of drugs from GSK

Irish-Israeli pharmaceutical company Perrigo is continuing its buying spree and does not seem perturbed by the hostile takeover attempts by Mylan NV, which has offered $34 billion in cash and shares for it. Perrigo, More...

Ilan Shavit On Tuesday, June 2nd, 2015

Mylan to Teva: stop playing games with our company

Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...

Niva Goldberg On Saturday, May 30th, 2015

Mylan’s CEO on Teva “They are getting ready to go off the cliff”

“We just don’t think Teva is the right company” to combine with, “They are getting ready to go off the cliff, ” Mylan NV, CEO Heather Bresch said Friday at a conference in New York City hosted More...

Wordpress site Developed by Fixing WordPress Problems